SageView Advisory Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-711
Closed -$47.2K 1098
2025
Q4
$47.2K Buy
+711
New +$46K ﹤0.01% 1098
2025
Q2
Sell
-3,542
Closed -$242K 622
2025
Q1
$242K Buy
+3,542
New +$289K 0.01% 530
2024
Q3
Sell
-3,206
Closed -$363K 523
2024
Q2
$363K Buy
+3,206
New +$405K 0.02% 396
2024
Q1
Sell
-2,847
Closed -$344K 573
2023
Q4
$344K Buy
+2,847
New +$291K 0.01% 471

Other funds holding DXCM

SageView Advisory Group's DXCM Position: Q1 2026 in Review

SageView Advisory Group sold out of DexCom (DXCM) in Q1 2026, closing a stake of 711 shares — an estimated $47.2K sold.

SageView Advisory Group first reported a position in DXCM in Q4 2023 and held it in 4 quarters. The position peaked at $363K in Q2 2024. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • SageView Advisory Group reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • SageView Advisory Group sold 711 DexCom shares in Q1 2026, an estimated $47.2K.
  • SageView Advisory Group first reported a position in DexCom in Q4 2023 and held it in 4 quarters.
  • SageView Advisory Group's DexCom position peaked at $363K in Q2 2024.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.